tiprankstipranks
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
Australian Market

Clarity Pharmaceuticals Ltd. (CU6) Income Statement

Compare
145 Followers

Clarity Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2024), Clarity Pharmaceuticals Ltd.'s total revenue was AU$6.09M, an increase of 199.34% from the same quarter last year. In Q4, Clarity Pharmaceuticals Ltd.'s net income was AU$-25.12M. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 11.51MAU$ 9.80MAU$ 6.46MAU$ 3.20MAU$ 2.79M
Gross Profit
AU$ 11.51MAU$ 9.70MAU$ 6.41MAU$ 3.18MAU$ 2.77M
Operating Expenses
AU$ 56.31MAU$ 36.06MAU$ 30.29MAU$ 13.49MAU$ 9.83M
Depreciation and Amortization
AU$ 153.07KAU$ 100.51KAU$ 46.25KAU$ 15.63KAU$ 17.00K
EBITDA
AU$ -44.65MAU$ -26.26MAU$ -17.00MAU$ -10.30MAU$ -7.04M
Operating Income
AU$ -44.80MAU$ -36.16MAU$ -30.29MAU$ -13.51MAU$ -9.85M
Other Income/Expenses
AU$ 2.77MAU$ 11.66MAU$ 5.90MAU$ 116.69KAU$ 405.31K
Pretax Income
AU$ -42.03MAU$ -34.30MAU$ -23.74MAU$ -13.39MAU$ -9.44M
Net Income
AU$ -42.32MAU$ -24.60MAU$ -23.75MAU$ -10.22MAU$ -6.95M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.15AU$ -0.09AU$ -0.10AU$ -0.04AU$ -0.03
Diluted EPS
AU$ -0.15AU$ -0.09AU$ -0.10AU$ -0.04AU$ -0.03
Weighted Average Shares Outstanding
273.16M 260.41M 248.47M 256.93M 256.93M
Weighted Average Shares Outstanding (Diluted)
273.16M 260.41M 248.47M 256.93M 256.93M
Currency in AUD

Clarity Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis